Lycopene Skin Randomized Trial Evidence Table

Structured evidence table for Lycopene Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Lycopene Skin Randomized TrialTogether, these mechanisms highlight lycopene’s multifaceted bioactivity in maintaining health and reducing the risk of noncommunicable diseases.3Hajareh Haghighi Farid (2026)Lycopene as Medicine: Unlocking the Therapeutic Power of a Bioactive Carotenoid
Lycopene Skin Randomized TrialWhile high-density lipoprotein (HDL) levels are not markedly increased, its functionality improves through enhanced antioxidant capacity and reverse cholesterol transport.3Hajareh Haghighi Farid (2026)Lycopene as Medicine: Unlocking the Therapeutic Power of a Bioactive Carotenoid
Lycopene Skin Randomized TrialRegular consumption of lycopene-rich foodssuch as tomatoes, watermelon, and guavawithin diets rich in antioxidants and anti-inflammatory compounds, like the Mediterranean diet, has been consistently associated with reduced cardiovascular morbidity and mortality.3Hajareh Haghighi Farid (2026)Lycopene as Medicine: Unlocking the Therapeutic Power of a Bioactive Carotenoid
Lycopene Skin Randomized Trial40 56 Figure Lycopene is a red carotenoid pigment known for its strong antioxidant properties and health benefits.3Hajareh Haghighi Farid (2026)Lycopene as Medicine: Unlocking the Therapeutic Power of a Bioactive Carotenoid
Lycopene Skin Randomized TrialDaily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesity.4Jilcott Pitts SB (2025)Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesity.

Source documents

  1. Lycopene as Medicine: Unlocking the Therapeutic Power of a Bioactive Carotenoid
  2. Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesity.